The relationship between ABO blood group and the risk of bleeding during vitamin K antagonist treatment

Angelina García; Jeroen F. van der Heijden; Joost C.M. Meijers; Frits R. Rosendaal; Pieter H. Reitsma

doi:10.1111/j.1538-7836.2006.01962.x

Related publications

Letter2004

ABO blood group genotypes and the risk of venous thrombosis: effect of factor V Leiden

Vânia M. Morelli, Marieke C. Visser, Hans L. Vos, Rogier M. Bertina, Frits R. Rosendaal

Journal of Thrombosis and Haemostasis

Article2013

Statin use and bleeding complications during treatment with vitamin K antagonists: a cohort study in 8188 patients with atrial fibrillation

Nienke van Rein, L.M. Willem, Suzanne C. Cannegieter, Frits R. Rosendaal, Pieter H. Reitsma, J.M. van der Meer

Journal of Thrombosis and Haemostasis

Letter2006

The effect of vitamin K supplementation on anticoagulant treatment

E.K. Rombouts, Frits R. Rosendaal, F.J.M. van der Meer

Journal of Thrombosis and Haemostasis

Article2007

Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin

D. Martijn O. Pruissen, Frits R. Rosendaal, J. W. Gorter, Ángeles García, L. Jaap Kappelle, Ale Algra

Journal of Neurology

Article2018

Data on incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants

Daniele Pastori, Professor Gregory Lip, Alessio Farcomeni, Francesco Del Sole, Angela Sciacqua, Francesco Perticone, Rossella Marcucci, Elisa Grifoni, Pasquale Pignatelli, Francesco Violi, Mirella Saliola, Marco Casciaro, Danilo Menichelli, Francesco Cribari, Alberto Paladino, Rony Gingis, Marta Novo, Vittoria Cammisotto, Cristina Nocella, Simona Bartimoccia, Roberto Carnevale,

The relationship between ABO blood group and the risk of bleeding during vitamin K antagonist treatment

Abstract

Discussion(0)

Related publications

ABO blood group genotypes and the risk of venous thrombosis: effect of factor V Leiden

Statin use and bleeding complications during treatment with vitamin K antagonists: a cohort study in 8188 patients with atrial fibrillation

The effect of vitamin K supplementation on anticoagulant treatment

Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin

Data on incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants